Status:
COMPLETED
The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
COVID 19
Lymphopenia Due to COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Recent studies have shown that lymphopenia with cytokine storm syndrome is frequently found in COVID-19 patients. These features may suggest that the modified immune system plays a key role in determi...
Eligibility Criteria
Inclusion
- Patients over the age of 18
- Male and female of both genders
- Admitted to the intensive care unit
- Diagnosed with Covid-19 with lymphopenia
- Patients with confirmed COVID-19 diagnosis in polymerase chain reaction (PCR) tests performed on nasopharyngeal swab samples
Exclusion
- Those with a negative PCR test
- Aged 18 and under
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06968156
Start Date
March 1 2020
End Date
September 30 2020
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)